Background There is a paucity of data comparing effectiveness of various techniques for pain management of traumatic rib fractures. This study compared the quality of analgesia provided by serratus anterior plane (SAP) catheters against thoracic epidural (TEA) or paravertebral catheters (PA) in patients with multiple traumatic rib fractures (MRFs).
Methods 354 patients who received either SAP, TEA or PA at two tertiary referral major trauma centers in the UK were included (2016–2018). Primary outcome were change in inspiratory volumes and pain scores. Secondary outcomes included in-hospital mortality, along with the length of stay in hospital and critical care. Data were analyzed using linear, log-binomial and negative binomial regression models.
Main results Across all blocks, there was a mean (SD) increase in inspiratory volume postblock of 789.4 mL (479.7). Ninety-eight per cent of all participants reported moderate/severe pain prior to regional analgesia, which was reduced to 34% postblock. There was no significant difference in the change in inspiratory volume or pain scores between the TEA, PA or SAP groups. Overall crude mortality was 13.2% (95% CI 7.8% to 18.7%). In an adjusted analysis and compared with TEA, in-hospital mortality was similar between groups (relative risk (RR) 0.4, 95% CI 0.1 to 1.0) and (RR 0.5, 95% CI 0.2 to 1.6) for SAP and PA, respectively.
Conclusion SAP, TEA and PA all appear to offer the ability to reduce pain scores and improve respiratory function.
- acute pain
- truncal blocks
- regional anesthesia
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Statistics from Altmetric.com
Twitter @carl_hillermann, @veenith_tonny
Contributors All those designated as authors meet the criteria for authorship as defined by the ICMJE recommendations.
Funding EB is funded by Cancer Research UK. FGS is supported by the National Institute for Health Research (NIHR) Senior Investigator Award. TV is supported by NIHR, CRN Research Scholar and Queen Elizabeth hospital charities.
Competing interests C Hillermann, L Beard, S Millerchip have had conference travel fees funded by Pajunk. E Beard has received unrestricted research funding from Pfizer for the Smoking Toolkit study (www.smokinginengland.info) outside of the period of this study. E Beard has no conflicts of interest to declare for this study.
Patient consent for publication Not required.
Ethics approval Institutional approval was obtained from both sites (GF0223/CARMS14833)
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available on reasonable request.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.